AAAAAA
Results: 1-25/28
Authors:
KAHN HJ
YANG LY
BLONDAL J
HANNA W
MARKS A
Citation: Hj. Kahn et al., DETECTION OF CIRCULATING TUMOR-CELLS IN PERIPHERAL-BLOOD OF BREAST-CANCER PATIENTS USING CK19 MESSENGER-RNA, Modern pathology, 11(1), 1998, pp. 21-21
Authors:
FEKETE E
FROM L
KAHN HJ
Citation: E. Fekete et al., TENASCIN DIFFERENTIATES DERMATOFIBROSARCOMA PROTUBERANS FROM DERMATOFIBROMA - COMPARISON WITH CD34 AND FACTOR XIIIA, Modern pathology, 11(1), 1998, pp. 49-49
Authors:
KAHN HJ
YANG LY
BLONDAL J
HANNA W
MARKS A
Citation: Hj. Kahn et al., DETECTION OF CALCULATING TUMOR-CELLS IN PERIPHERAL-BLOOD OF BREAST-CANCER USING CK19MRNA, Laboratory investigation, 78(1), 1998, pp. 103-103
Authors:
TSOPORIS JN
MARKS A
KAHN HJ
BUTANY JW
LIU PP
OHANLON D
PARKER TG
Citation: Jn. Tsoporis et al., INHIBITION OF NOREPINEPHRINE-INDUCED CARDIAC-HYPERTROPHY IN S100-BETATRANSGENIC MICE, The Journal of clinical investigation, 102(8), 1998, pp. 1609-1616
Authors:
KAHN HJ
Citation: Hj. Kahn, DESIGN TO MANUFACTURE - AN INTEROPERABILITY NIGHTMARE, Electronic engineering, 70(858), 1998, pp. 47-47
Authors:
HANNA WM
KAHN HJ
CHAPMAN JW
MCCREADY DR
Citation: Wm. Hanna et al., THE EFFECT OF RBPROTEIN (PRB) EXPRESSION ON RECURRENCE AND DISEASE-SPECIFIC DEATH IN BREAST-CANCER, Laboratory investigation, 76(1), 1997, pp. 95-95
Authors:
KAHN HJ
YANG LY
PIENKOWSKA M
GUPTA KC
SETH A
HANNA WM
MARKS A
Citation: Hj. Kahn et al., CK19MRNA AS A POTENTIAL MARKER OF CIRCULATING TUMOR-CELLS IN PERIPHERAL-BLOOD OF BREAST-CANCER PATIENTS, Laboratory investigation, 76(1), 1997, pp. 102-102
Authors:
TSOPORIS JN
MARKS A
KAHN HJ
BUTANY JW
LIU PP
OHANLON D
PARKER TG
Citation: Jn. Tsoporis et al., S100-BETA INHIBITS ALPHA(1)-ADRENERGIC INDUCTION OF THE HYPERTROPHIC PHENOTYPE IN CARDIAC MYOCYTES, The Journal of biological chemistry, 272(50), 1997, pp. 31915-31921
Authors:
CHAPMAN JW
HANNA W
KAHN HJ
LICKLEY HLA
WALL J
FISH EB
MCCREADY DR
Citation: Jw. Chapman et al., ALTERNATIVE MULTIVARIATE MODELING FOR TIME TO LOCAL RECURRENCE FOR BREAST-CANCER PATIENTS RECEIVING A LUMPECTOMY ALONE, Surgical oncology, 5(5-6), 1996, pp. 265-271
Authors:
CHAPMAN JW
MURRAY D
MCCREADY DR
HANNA W
KAHN HJ
LICKLEY HLA
TRUDEAU ME
MOBBS BG
SAWKA CA
FISH EB
PRITCHARD KI
Citation: Jw. Chapman et al., AN IMPROVED STATISTICAL APPROACH - CAN IT CLARIFY THE ROLE OF NEW PROGNOSTIC FACTORS FOR BREAST-CANCER, European journal of cancer, 32A(11), 1996, pp. 1949-1956
Authors:
PASTOLERO G
HANNA W
ZBIERANOWSKI I
KAHN HJ
Citation: G. Pastolero et al., PROLIFERATIVE ACTIVITY AND P53 EXPRESSION IN ADENOID CYSTIC CARCINOMAOF THE BREAST, Modern pathology, 9(3), 1996, pp. 215-219
Authors:
KAHN HJ
Citation: Hj. Kahn, NEUROSCIENCE FOR THE STUDY OF COMMUNICATIVE DISORDERS - BHATNAGER,SC,ANDY,OJ, Brain and cognition, 32(1), 1996, pp. 83-86
Authors:
KAHN HJ
Citation: Hj. Kahn, CONTROLLING FOR VARIABILITY IN RESEARCH ON NORMAL AGING AND NEUROPSYCHOLOGICAL POPULATIONS - BLOOM,RL, OBLER,LK, DESANTI,S, ERLICH,JS, Brain and language, 53(3), 1996, pp. 408-416
Authors:
KAHN HJ
KWONG J
KELLETT L
SACHACKTER R
Citation: Hj. Kahn et al., THE EXPRESSION OF MIB1, RETINOBLASTOMA GENE PROTEIN, BCL2 AND CK14 PSORIASIS, Laboratory investigation, 74(1), 1996, pp. 233-233
Authors:
RAMSAY JA
FROM L
KAHN HJ
Citation: Ja. Ramsay et al., BCL-2 PROTEIN EXPRESSION IN MELANOCYTIC NEOPLASMS OF THE SKIN, Modern pathology, 8(2), 1995, pp. 150-154
Authors:
KAHN HJ
HANNA WM
Citation: Hj. Kahn et Wm. Hanna, ABERRANT ELASTIC IN ELASTOFIBROMA - AN IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY, Ultrastructural pathology, 19(1), 1995, pp. 45-50
Authors:
HANNA W
KAHN HJ
GHAZARIAN D
MCCREADY D
Citation: W. Hanna et al., P53 PROTEIN EXPRESSION AND MIB-1 PROLIFERATIVE ACTIVITY ARE INDICATORS OF AGGRESSIVE BIOLOGICAL BEHAVIOR IN INFILTRATING LOBULAR CARCINOMA, Laboratory investigation, 72(1), 1995, pp. 18-18
Authors:
KAHN HJ
BUTANY J
PARKER TG
MARKS A
Citation: Hj. Kahn et al., ABERRANT EXPRESSION OF S100-BETA IN HEART-DISEASE, Laboratory investigation, 72(1), 1995, pp. 33-33
Authors:
RAMSAY JA
KAHN HJ
FROM L
Citation: Ja. Ramsay et al., BCL-2 PROTEIN EXPRESSION IN SQUAMOUS-CELL AND BASAL-CELL CARCINOMAS OF THE SKIN, Laboratory investigation, 72(1), 1995, pp. 49-49
MIB-1 PROLIFERATIVE ACTIVITY IS A SIGNIFICANT PROGNOSTIC FACTOR IN PRIMARY THICK CUTANEOUS MELANOMAS
Authors:
RAMSAY JA
FROM L
ISCOE NA
KAHN HJ
Citation: Ja. Ramsay et al., MIB-1 PROLIFERATIVE ACTIVITY IS A SIGNIFICANT PROGNOSTIC FACTOR IN PRIMARY THICK CUTANEOUS MELANOMAS, Journal of investigative dermatology, 105(1), 1995, pp. 22-26
Authors:
AKASU R
FROM L
KAHN HJ
Citation: R. Akasu et al., CHARACTERIZATION OF THE MONONUCLEAR INFILTRATE INVOLVED IN REGRESSIONOF HALO NEVI, Journal of cutaneous pathology, 21(4), 1994, pp. 302-311
Authors:
HANNA W
KAHN HJ
MCCREADY DR
CHAPMAN JW
FISH EB
LICKLEY L
Citation: W. Hanna et al., PREDICTORS FOR LOCAL RECURRENCE OF BREAST-CANCER TREATED WITH LUMPECTOMY ALONE, Laboratory investigation, 70(1), 1994, pp. 10000016-10000016
Authors:
KAHN HJ
RAMSAY JA
FROM L
ISCOE N
Citation: Hj. Kahn et al., MIB-1 PROLIFERATIVE ACTIVITY IS A SIGNIFICANT INDICATOR OF SURVIVAL IN PRIMARY THICK CUTANEOUS MELANOMA, Laboratory investigation, 70(1), 1994, pp. 10000046-10000046
Authors:
GOULET P
SKA B
KAHN HJ
Citation: P. Goulet et al., IS THERE A DECLINE IN PICTURE NAMING WITH ADVANCING AGE, Journal of speech and hearing research, 37(3), 1994, pp. 629-644
Authors:
FROM L
RAMSAY JA
KAHN HJ
ISCOE NA
Citation: L. From et al., MIB-1 PROLIFERATIVE ACTIVIN IS A SIGNIFICANT PROGNOSTIC FACTOR IN PRIMARY THICK CUTANEOUS MALIGNANT MELANOMAS, Journal of investigative dermatology, 103(2), 1994, pp. 271-271